Thursday, October 29, 2026

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $22B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 29 3 clicks

Oct 29 INTC $348B

Intel Q3 2026: Dead Inside

Irrational Analysis 2 clicks

Oct 29 INTC $348B

INTC Q3 FY12/26 Earnings Review

Cestrian Capital Research 4 clicks

From X

@Mr_Neutral_Man Oct 29 1 click

Mr Neutral Man aka "Howard Marks of REITs” on X

@TimelessArie Ticker is $INVH for those curious

@Mr_Neutral_Man Oct 29

Mr Neutral Man aka "Howard Marks of REITs” on X

More $CUBE news Sold 80% to Heitman in a JV valued $197mm at a roughly mid 5% cap rate and used proceeds to buy back better assets like those in NYC in that 6.3% to 6.5% cap rate range Improves quality and sell non-core at lower cap rate than higher quality assets Retains management and builds annuity mgt fee stream

@negligible_cap Oct 29

Negligible Capital on X

Thats cool $GOOG shareholders lost around $500B today https://t.co/ejv9K0CnIy

@ChrisCamillo Oct 29

Chris Camillo on X

I’ve never been my personal brand. $AMZN is too significant a holding for me not to share meaningful trading decisions with my followers. But the real value isn’t in the trade. It’s in understanding the rationale behind it which was outlined by posts and on today’s @DumbMoneyTV. That’s how people learn.

@Mr_Neutral_Man Oct 29

Mr Neutral Man aka "Howard Marks of REITs” on X

I have consistently talked about buying $CUBE in the past year and highlighted their incredible NYC/NNJ portfolio It accounts for 1/4 of the company's NOI, up 5.5% in Q3 on a YOY basis. Moves the needle. Overall NOI up 2.1% YOY High barrier, no rent regs like housing, truly a great asset NOI declines mostly in Sunbelt high supply markets Story is as old as time Bought at a rough 6.7% cap about a year ago at $36 ish now $41.08 plus about $2.12 in dividends since Not too shabby for a 20% one year return for buying a high quality SS with low leverage

@BarbarianCap Oct 29

Barbarian Capital on X

Roblox Narrows Loss as User, Engagement Metrics Fall The video-game company said average daily users were down 9% to 138 million, and engagement hours fell 15% to 34 billion. $RBLX https://t.co/KQM4qbpsbd

@ACapitalLP Oct 29

A Capital on X

$FSLR interesting here at ~7–8x 2027 earnings with 44GW of contracted backlog. Q3 bookings at ~$0.36/W were largely negotiated pre-232, while management is already quoting higher prices on new business. Think the first meaningful post-232 contracts will be particularly informative as to normalized earnings power and ultimately where this should trade…

@orrdavid Oct 29

David Orr on X

$PURR https://t.co/yeJJ2cHVeE

Alphabet: Why I'm Buying The Free Cash Flow Scare

Alphabet's EPS miss came from a SpaceX stake loss, while 24.7% revenue growth and a $561 billion Cloud backlog counter free cash flow…

GOOGL $4T

Cain Lee Oct 29 1 click

Incyte (INCY) Q3 FY 12/26 Earnings Review

Incyte reported Q3 FY26 revenue of $1.56 billion, up 14%, while a $1.23 billion Vega acquisition charge drove a $708 million operating loss.

INCY $24B

Cestrian Capital Research Oct 29 2 clicks

Merck and Co. (MRK) Q3 FY 12/26 Earnings Review

Merck reported Q3 FY26 revenue of $18.1 billion, led by $8.6 billion in KEYTRUDA sales and 93% WINREVAIR growth, while raising and…

MRK $369B

Cestrian Capital Research Oct 29 2 clicks

Alphabet 3Q’26: Search Worries Weighing In

Alphabet’s Search growth slowed to 12% as Cloud revenue more than doubled, while quarterly free cash flow stayed negative amid the capex…

GOOGL $4T

MBI Deep Dives Oct 29 2 clicks

CoStar: 3Q26 Business Recap

CoStar’s 3Q26 revenue growth slowed to 14% as bookings fell to $37 million, while cost cuts lifted EBIT margin to 8.8%.

CSGP $12B

Speedwell Memos Oct 29 3 clicks

Ex-Goldman Oil Derivatives Trader: Every Trading Strategy Is Momentum or Mean Reversion

Simran Jeet Singh recounts pricing oil through WTI’s -$37.63 collapse, then explains crypto perpetual funding arbitrage, market making and…

GS $260B

Odds on Open Oct 29 5 clicks

Carpenter Technology (CRS) Q1'27: The Sell-Off Resets the Entry Point

Carpenter Technology fell 25% after Q1 2027 despite revenue rising 9%, EPS up 34%, and commercial aerospace bookings up 25%.

CRS $15B

Monte Independent Investment Research Oct 29 3 clicks

GE Vernova: 3 Straight Guidance Raises, And Wall Street Still Doubts It

GE Vernova raised guidance for a third straight quarter as Power and Electrification drove backlog growth, while Wind showed an early…

GEV $234B

Melissa Tucker Oct 29 1 click

Alphabet Inc Earnings Update: Fiscal Q1 2027

Alphabet reported $127.6 billion in revenue, up 25%, as Google Cloud doubled to $30.7 billion and 36.2% margins.

GOOGL $4T

SixSigmaCapital: Navigating the Financial Markets Oct 29 1 click

Alamos Gold: Minor Delays With Island Gold Growth, But There Is Still A Lot Of Value Here

Alamos Gold targets nearly 1 Moz of annual production by decade-end as Island Gold shaft commissioning offsets recent Young-Davidson…

AGI $12B

Bang For The Buck Oct 29 1 click

CHGG · long

Chegg Inc

Chegg is framed as a binary long with 500% upside against 20% downside.

CHGG $77M

Value Investors Club Jul 22 15 clicks

My 2028 numbers

ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…

ASML $610B

Best Anchor Stocks Oct 14 27 clicks

Visa: Unpacking The 7 Powers And Forward Valuation Ahead Of Q4 Earnings

Visa’s network economics support long-term compounding, but a 1.7–1.8 forward PEG and risks to high-margin payment revenues limit near-term…

V $749B

C Jessen Oct 14 36 clicks

Deep Dive: Applied Materials ($AMAT)

Applied Materials leads wafer-fab deposition and ranks third in etch, positioning it for tougher 3D chip manufacturing as investors weigh a…

AMAT $310B

Rebound Capital Oct 14 32 clicks

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TRAX $1.9BTEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $80BJBHT $21B

Monte Independent Investment Research Oct 14 16 clicks

Palantir Is Not C3.Ai, But C3.Ai Wrote Its Watch List - Downgrade Palantir To Hold, Sell C3.Ai

Palantir is cut to Hold after a 35% multiple-driven rally, while C3.ai is rated Sell on stalled revenue, expensive valuation and weak…

PLTR $472B

The Alpha Analyst Oct 14 11 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $22B

Latticework by MOI Global Oct 14 16 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $22B

Latticework by MOI Global Oct 14 15 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $22B

Latticework by MOI Global Oct 14 13 clicks

Thursday, October 29, 2026

Mr Neutral Man aka "Howard Marks of REITs” on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Negligible Capital on X

Chris Camillo on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Barbarian Capital on X

A Capital on X

David Orr on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 268

X accounts we follow

Investor letters we follow

Sectors